We are live on
!
Find out more
ICM
Irenic Capital Management Portfolio holdings
AUM
$1.54B
1-Year Est. Return
12.79%
This Fund
S&P 500
This Quarter
Est. Return
+7.83%
1 Year Est. Return
+12.79%
3 Year Est. Return
+78.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$45M
(+16%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-6.87%
Top 10 Holdings %
Top 10 Hldgs %
93.12%
Holding
21
New
4
Increased
2
Reduced
1
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Reservoir Media
RSVR
|
+$13.5M |
| 2 |
ENFN
Enfusion, Inc.
ENFN
|
+$10.6M |
| 3 |
Sotera Health
SHC
|
+$2.03M |
| 4 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
+$89.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIV
Aimco
AIV
|
+$12.3M |
| 2 |
Stagwell
STGW
|
+$3.42M |
| 3 |
Alkami Technology
ALKT
|
+$2.26M |
| 4 |
Lifecore Biomedical
LFCR
|
+$587K |
| 5 |
Cogent Communications
CCOI
|
+$159K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 54.44% |
| 2 | Healthcare | 12.63% |
| 3 | Technology | 4.01% |
| 4 | Industrials | 3.17% |
| 5 | Real Estate | 0% |
Similar funds
CCM
MCP
CET
FI
FBB
SG
HR
CCP
Irenic Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Irenic Capital Management held 21 positions worth $335M, up 16% from $290M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Irenic Capital Management withdrew a net $23M in Q2 2023, closing 6 positions and reducing 1 holding. Its most notable exit was Aimco, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 54% of assets, up from 53% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Irenic Capital Management opened a new position in Reservoir Media worth $12.9M.
- Irenic Capital Management's largest Q2 2023 buy was Reservoir Media: 2,139,131 shares worth $12.9M.
- Irenic Capital Management added most to Sotera Health in Q2 2023, an estimated $2.03M increase.
- Irenic Capital Management's biggest Q2 2023 reduction was Theravance Biopharma, cutting an estimated $34.2K.
- Irenic Capital Management fully exited Aimco in Q2 2023, selling an estimated $12.3M.
- Irenic Capital Management's ten largest holdings make up 93% of its $335M portfolio in Q2 2023.
- Irenic Capital Management opened 4 new positions and closed 6 in Q2 2023.
- Irenic Capital Management's portfolio value rose 16% quarter-over-quarter to $335M.
Based on Irenic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.